- Chronic Administration of Valproic Acid Inhibits Prostate Cancer Cell Growth In vitro and In vivo
Qinghua Xia et al, 2006, Cancer Research CrossRef - Valproic Acid Alters Chromatin Structure by Regulation of Chromatin Modulation Proteins
Douglas C. Marchion et al, 2005, Cancer Research CrossRef - Cancer Risk in Long-term Users of Valproate: A Population-Based Case-Control Study
Jesper Hallas et al, 2009, Cancer Epidemiology, Biomarkers & Prevention CrossRef - Thrombospondin-1 Peptide ABT-510 Combined with Valproic Acid Is an Effective Antiangiogenesis Strategy in Neuroblastoma
Qiwei Yang et al, 2007, Cancer Research CrossRef - Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC
Xiao-Nan Li et al, 2005, Molecular Cancer Therapeutics CrossRef - In vivo synergy between topoisomerase II and histone deacetylase inhibitors: predictive correlates
Douglas C. Marchion et al, 2005, Molecular Cancer Therapeutics CrossRef - Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy
Amit Singh et al, 2018, Nutrients CrossRef - Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al, 2017, International Journal of Molecular Sciences CrossRef